Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital Tuebingen
Novel hybrid devices combine magnetic resonance imaging (MRI) and a linear accelerator in a single device. The superior soft tissue contrast compared with cone-beam computed tomography based treatment and the possibility for daily plan adaptation promise a higher precision of treatment, better target volume coverage and normal tissue sparing. In a first step the present study will test the feasibility of imaging and treatment on the 1.5 T MR-Linac.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
existing indication for radiation therapy
minimum age 18 years, no upper age limit
capacity for consent
Informed consent
You may not be if
contraindication for MRI (claustrophobia, metallic implants not applicable for MRI
pregnancy
Clareo Health | Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac
